Cargando…
Cefepime in critically ill patients: continuous infusion versus intermittent regimen
Autores principales: | Georges, B, Saivin, S, Cougot, P, Decun, JF, Andrieu, P, Archambaud, M, Roche, Ch, Chaminade, B, Fuzier, R, Mazerolles, M, Suc, Ch, Houin, G, Lavrard, I, Samii, K, Virenque, Ch |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2001
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3333280/ http://dx.doi.org/10.1186/cc1160 |
Ejemplares similares
-
Hemodynamics changes induced by volume expansion measured by PiCCO(®) system: the post-expansion effect
por: Cougot, P, et al.
Publicado: (2001) -
Cefepime extended infusion versus intermittent infusion: Clinical and cost evaluation
por: Khole, Aalok V., et al.
Publicado: (2023) -
Outcomes of Intravenous Push versus Intermittent Infusion Administration of Cefepime in Critically Ill Patients
por: Smith, Susan E., et al.
Publicado: (2023) -
1306. Comparison of the Use of Extended and Intermittent Infusion Cefepime and Piperacillin/tazobactam in Non-critically Ill, Obese Patients
por: Marg, Carolyn, et al.
Publicado: (2020) -
2244. Clinical Outcomes with Extended Infusion (EI) vs. Intermittent Infusion (II) of Cefepime (FEP), Piperacillin/Tazobactam (TZP), and Meropenem (MEM) in Patients with Gram-Negative (GN) Bacteremia
por: Tran, Kieu-Nhi, et al.
Publicado: (2019)